Meeting
2019 Gastrointestinal Cancers Symposium
Impact of antibiotic use on response to treatment with immune checkpoint inhibitors.
Authors
Uqba Khan
Weill Cornell Medical College, New York, NY
Uqba Khan , Cristian Peña , Julianna Brouwer , Katherine Hoffman , Arindam Roy Choudhury , Chao Zhang , Prashant Thakkar , Doron Betel , Sandipto Sarkar , Gregory Sonnenberg , Ashish Saxena , Manish A. Shah
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cancers of the Esophagus and Stomach
Track
Cancers of the Esophagus and Stomach
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 37, 2019 (suppl 4; abstr 143)
DOI
10.1200/JCO.2019.37.4_suppl.143
Abstract #
143
Poster Bd #
L15
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
The effect of antibiotic (Abx) use on immune checkpoint inhibitor (ICI) efficacy in patients (pts) with metastatic urothelial carcinoma (mUC) in a real-world setting.
First Author: Ubenthira Patgunarajah
Poster
2021 Genitourinary Cancers Symposium
The effect of antibiotic use within 30 days of initiation of immune checkpoint inhibitor (ICI) efficacy in patients with metastatic urothelial carcinoma (mUC) in real-world setting.
First Author: Shilpa Gupta
First Author: Igor Tsaur
Poster
2024 ASCO Annual Meeting
Effect of antibiotic, proton pump inhibitor, H2 blocker, metformin and statin use on outcomes with immune checkpoint inhibitors (ICIs) in patients (pts) with metastatic urothelial carcinoma (mUC) in a real-world setting.
First Author: Charbel Hobeika